DGX vs GEHC
DGX: A leading national provider of diagnostic testing and medical insights, delivering clinical laboratory services through an extensive network of patient centers and hospitals. GEHC: GE HealthCare is a leading global medical technology provider delivering advanced diagnostic imaging, clinical systems, and intelligent digital solutions to healthcare providers worldwide.
Side-by-side fundamentals
| Metric | DGX | GEHC | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $231.84 | $61.12 | |
| Market cap as of 2026-07-31 | $25.8B | $27.8B | |
| P/E as of 2026-07-31 | 24.30 | 16.66 | GEHC lower |
| PEG as of 2026-07-31 | 2.41 | 2.18 | GEHC lower |
| Net margin as of 2026-07-31 | +9.2% | +9.1% | DGX higher |
| Gross margin as of 2026-07-31 | +33.2% | +39.1% | GEHC higher |
| Operating margin as of 2026-07-31 | +14.1% | +12.6% | DGX higher |
| ROE as of 2026-07-31 | +14.5% | +18.8% | GEHC higher |
| ROA as of 2026-07-31 | +6.4% | +5.3% | DGX higher |
| Debt / equity as of 2026-07-31 | 0.75 | 0.95 | DGX lower |
| Revenue growth (YoY) as of 2026-07-31 | +9.9% | +6.0% | DGX higher |
| Revenue CAGR (3y) SEC XBRL | +3.7% | +4.0% | GEHC higher |
| Dividend yield as of 2026-07-31 | +1.5% | +0.2% | DGX higher |
| Dividend streak (yrs) SEC XBRL | 5 | 3 | DGX higher |
| Beta as of 2026-07-31 | 0.54 | 0.79 | |
| 1-year return as of 2026-07-27 close | +37.5% | -21.2% | DGX higher |
Fundamentals: market data, as of 2026-07-31. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.